Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Sales (2023 - 2025)

Mangoceuticals' Return on Sales history spans 3 years, with the latest figure at 90.43% for Q3 2025.

  • For Q3 2025, Return on Sales fell 7544.0% year-over-year to 90.43%; the TTM value through Sep 2025 reached 42.46%, down 3010.0%, while the annual FY2024 figure was 14.14%, 154.0% down from the prior year.
  • Return on Sales for Q3 2025 was 90.43% at Mangoceuticals, down from 32.22% in the prior quarter.
  • Across five years, Return on Sales topped out at 7.34% in Q3 2023 and bottomed at 90.43% in Q3 2025.
  • The 3-year median for Return on Sales is 16.17% (2023), against an average of 25.96%.
  • The largest annual shift saw Return on Sales skyrocketed 1437bps in 2024 before it tumbled -7544bps in 2025.
  • A 3-year view of Return on Sales shows it stood at 10.51% in 2023, then plummeted by -76bps to 18.51% in 2024, then plummeted by -388bps to 90.43% in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Return on Sales are 90.43% (Q3 2025), 32.22% (Q2 2025), and 44.27% (Q1 2025).